NLRP3 and hematoma: In a collagenase-induced ICH mouse model, verapamil administration has demonstrated efficacy in reducing TXNIP and NLRP3 expression around the hematoma region, inhibiting NF-κB activation, facilitating hematoma clearance, and improving both neuroinflammation and blood-brain barrier dysfunction (88).